pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 6·1 min read
save

Biotech leader Greg Verdine enjoys a successful year with multiple wins

Aug 6, 2026·read at STAT ↗Positive

Greg Verdine, a scientist who moved into biotech leadership, is reported to be having a very good year.

According to the source, Verdine has notched several wins in his role, though the specifics are not detailed.

He appears to be enjoying the momentum and positive results as he continues to lead his company.

source

This writeup was produced by pharmadog from original reporting by STAT. The original article may no longer be reachable at its published URL.

Original headline: “STAT+: A scientist-turned-biotech executive is notching some wins, and enjoying it”

read at STAT ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 2h agoSTAT+: Radiopharma companies merge after one receives surprise FDA rejectionSTAT
  • 1d agoJehovah’s Witnesses allow blood-derived products but keep ban on whole-blood transfusionsSTAT
  • 2d agoSTAT+: Trump touts pharma deals to offer cheaper drugs to state Medicaid programsSTAT
  • 2d agoSTAT+: In a fight over denied claims, HCA sues out-of-state Blue Cross Blue Shield planSTAT
  • 2d agoSTAT+: Roche expands its Boston footprint with new research centerSTAT